Guideline on biosimilar medicines

This document describes the regulatory framework for biosimilar medicines in the European Union, including their definition, development and approval procedures, and the safety of biosimilar medicines.


File format
PDF
Published
25 November, 2023
Updated
25 November, 2023
MD5 checksum
09CCCA663896BD7B9DADC4658EB9D14B
Download PDF

Also Manuals